File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy

TitleThe importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy
Authors
Keywordsadiponectin
caveolin 1
caveolin 3
diabetic cardiomyopathy
insulin signal pathway
oxidative stress
Issue Date2-Nov-2022
PublisherFrontiers Media
Citation
Frontiers in Immunology, 2022, v. 13 How to Cite?
Abstract

The diabetic population has been increasing in the past decades and diabetic cardiomyopathy (DCM), a pathology that is defined by the presence of cardiac remodeling and dysfunction without conventional cardiac risk factors such as hypertension and coronary heart diseases, would eventually lead to fatal heart failure in the absence of effective treatment. Impaired insulin signaling, commonly known as insulin resistance, plays an important role in the development of DCM. A family of integral membrane proteins named caveolins (mainly caveolin-1 and caveolin-3 in the myocardium) and a protein hormone adiponectin (APN) have all been shown to be important for maintaining normal insulin signaling. Abnormalities in caveolins and APN have respectively been demonstrated to cause DCM. This review aims to summarize recent research findings of the roles and mechanisms of caveolins and APN in the development of DCM, and also explore the possible interplay between caveolins and APN.


Persistent Identifierhttp://hdl.handle.net/10722/338267
ISSN
2021 Impact Factor: 8.786
2020 SCImago Journal Rankings: 2.646
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorXia, WY-
dc.contributor.authorLi, X-
dc.contributor.authorWu, QP-
dc.contributor.authorXu, AM-
dc.contributor.authorZhang, LQ-
dc.contributor.authorXia, ZY-
dc.date.accessioned2024-03-11T10:27:35Z-
dc.date.available2024-03-11T10:27:35Z-
dc.date.issued2022-11-02-
dc.identifier.citationFrontiers in Immunology, 2022, v. 13-
dc.identifier.issn1664-3224-
dc.identifier.urihttp://hdl.handle.net/10722/338267-
dc.description.abstract<p>The diabetic population has been increasing in the past decades and diabetic cardiomyopathy (DCM), a pathology that is defined by the presence of cardiac remodeling and dysfunction without conventional cardiac risk factors such as hypertension and coronary heart diseases, would eventually lead to fatal heart failure in the absence of effective treatment. Impaired insulin signaling, commonly known as insulin resistance, plays an important role in the development of DCM. A family of integral membrane proteins named caveolins (mainly caveolin-1 and caveolin-3 in the myocardium) and a protein hormone adiponectin (APN) have all been shown to be important for maintaining normal insulin signaling. Abnormalities in caveolins and APN have respectively been demonstrated to cause DCM. This review aims to summarize recent research findings of the roles and mechanisms of caveolins and APN in the development of DCM, and also explore the possible interplay between caveolins and APN.</p>-
dc.languageeng-
dc.publisherFrontiers Media-
dc.relation.ispartofFrontiers in Immunology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectadiponectin-
dc.subjectcaveolin 1-
dc.subjectcaveolin 3-
dc.subjectdiabetic cardiomyopathy-
dc.subjectinsulin signal pathway-
dc.subjectoxidative stress-
dc.titleThe importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy-
dc.typeArticle-
dc.identifier.doi10.3389/fimmu.2022.951381-
dc.identifier.pmid36405687-
dc.identifier.scopuseid_2-s2.0-85142151760-
dc.identifier.volume13-
dc.identifier.eissn1664-3224-
dc.identifier.isiWOS:000885619200001-
dc.publisher.placeLAUSANNE-
dc.identifier.issnl1664-3224-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats